- Pharmaceutical companies
- Europe
- France
- Jazz Pharmaceuticals
Jazz Pharmaceuticals in France
Web: https://www.jazzpharma.com/
Address:
-
CityOne 84 quai Charles de Gaulle 69006 Lyon France
Phone: +33 4 37 49 85 85
Other Jazz Pharmaceuticals's locations around the world
Clinical Trials sponsored by Jazz Pharmaceuticals
-
Jazz PharmaceuticalsReclutamentoMalattia neuropsichiatrica associata al complesso della sclerosi tuberosaStati Uniti, Regno Unito, Polonia
-
Jazz PharmaceuticalsReclutamentoMorbo di Parkinson | TremoreStati Uniti, Spagna, Germania, Polonia
-
Jazz PharmaceuticalsReclutamentoTumore solido | Cancro metastatico | Cancro avanzatoStati Uniti
-
Jazz PharmaceuticalsReclutamentoComplesso di sclerosi tuberosa | Sindrome di Dravet | Sindrome di Lennox GastautStati Uniti
-
Jazz PharmaceuticalsReclutamento
-
Jazz PharmaceuticalsAttivo, non reclutanteTumori gastrointestinali che esprimono HER2, tra cui l'adenocarcinoma gastroesofageo, il cancro del tratto biliare e il cancro del colon-rettoStati Uniti, Corea, Repubblica di, Chile, Canada
-
Jazz PharmaceuticalsAttivo, non reclutanteTumori che esprimono HER2Stati Uniti, Canada, Corea, Repubblica di
-
Jazz PharmaceuticalsCompletatoMonoterapia con lurbinectedina in partecipanti con tumori solidi avanzati o metastatici (EMERGE-201)Tumore solido avanzato | Tumore solido metastatico | Cancro uroteliale | Carcinomi neuroendocrini scarsamente differenziati | Ricombinazione omologa Carenza di tumori maligni positivi agnosticiStati Uniti
-
Jazz PharmaceuticalsTerminatoSpasticità con sclerosi multiplaSpagna, Stati Uniti, Regno Unito, Cechia, Polonia
-
Jazz PharmaceuticalsAttivo, non reclutante
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Through continued investment in an evolving and growing research and development focus, we seek solutions for rare or complex diseases, and ensure those solutions are available for the often-overlooked patients who need them. Our approach has allowed us to shepherd new medicines to market – from late-stage discovery through clinical development and regulatory approval. All of these advancements are a reflection of our continued investment in an evolving and growing research and development focus.